Anna Gloyn, PhD is the recipient of the 2022 Outstanding Scientific Achievement Award, which recognizes research in diabetes that demonstrates particular independence of thought and originality.
Extraordinary Leaders in Diabetes Research, Prevention, and Treatment to be Recognized at ADA’s 82nd Scientific Sessions
Previous
Previous
Early Use of Diabetes Technology Drives Better Patient Outcomes in Kids
Next
Next